Drug Chatter -- Tracking biopharma stock chatter

Profile for Karyopharm Therapeutics Inc. (KPTI)

« Back to company index

KPTI Chatter Timeline

Stock Ticker for KPTI

Most Active Tweeters for KPTI

UserTweets
@tom_mcdaniels 12
@TickerReport 11
@ConsumerFeed 10
@AmericanBanking 9
@dispatchtribune 8

Recent Tweets for KPTI

TranscriptDaily @TranscriptDaily
Karyopharm Therapeutics $KPTI Given Average Rating of “Buy” by Brokerages https://t.co/p2l7Ida5GR
May 25th 2018, 12:05pm
WeekHerald @WeekHerald
Karyopharm Therapeutics $KPTI Receives Average Rating of “Buy” from Brokerages https://t.co/57BudVvtkr
May 25th 2018, 11:05am
dailypoliticaln @dailypoliticaln
Karyopharm Therapeutics $KPTI Downgraded by Wedbush to Neutral https://t.co/wtjwDiKSu1
May 25th 2018, 9:05am
TickerReport @TickerReport
Karyopharm Therapeutics $KPTI Lowered to Neutral at Wedbush https://t.co/h4hVPkjoUf
May 25th 2018, 9:05am
WatchlistN @WatchlistN
Q1 2019 Earnings Forecast for Karyopharm Therapeutics $KPTI Issued By Wedbush https://t.co/KO8voguym4
May 25th 2018, 8:05am
RatingsNetwork @RatingsNetwork
Wedbush Sets Karyopharm Therapeutics Q1 2019 Earnings Estimates at ($0.75) EPS. https://t.co/nQrL9degOB $KPTI #KPTI
May 25th 2018, 7:05am
tom_mcdaniels @tom_mcdaniels
My take on the Wedbush down grade of $kpti. “ we rated it outperform with a $20 target. It hit our target. We are d… https://t.co/3vaVqoG70l
May 25th 2018, 7:05am
dakotafinancial @dakotafinancial
Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/UtOIVltLd5
May 25th 2018, 3:05am
ZolmaxNews @ZolmaxNews
Research Analysts Offer Predictions for Karyopharm Therapeutics’ FY2018 Earnings $KPTI https://t.co/v74jf9GOqG
May 25th 2018, 2:05am
ChartMill @ChartMill
$KPTI shows a strong growth in Revenue. Over the last 5 years it has been growing by 97.19% yearly.… https://t.co/FiIGZj0jTU
May 25th 2018, 12:05am
pennpenn2323 @pennpenn2323
@ObserverBio I am very happy with my purchase of $KPTI shares below $17.50 :)
May 24th 2018, 10:05pm
dakotafinancial @dakotafinancial
Zacks: Analysts Expect Karyopharm Therapeutics $KPTI Will Post Earnings of -$0.82 Per Share https://t.co/nPOpga00qS
May 24th 2018, 3:05pm
MarketChmln @MarketChmln
$KPTI share price decreases -7.8%. See recent news release. https://t.co/zaxhLKZtTu
May 24th 2018, 3:05pm
ZolmaxNews @ZolmaxNews
Insider Selling: Karyopharm Therapeutics $KPTI CEO Sells $193,900.00 in Stock https://t.co/2Vkzau1NXH
May 24th 2018, 2:05pm
Wedbush @Wedbush
Wedbush's David Nierengarten, Ph.D. Downgrades Karyopharm Therapeutics $KPTI to #Neutral from #Outperform on Shares… https://t.co/LLcPFycndF
May 24th 2018, 12:05pm
JUSTUSnatuhwera @JUSTUSnatuhwera
RT @Briefingcom: $KPTI: Wedbush cuts to Neutral
May 24th 2018, 11:05am
AlertTrade @AlertTrade
UP/DOWNGRADES ? $KPTI: Wedbush cuts to Neutral https://t.co/EuvOWJT6kX via ? https://t.co/VS8RO1bzXJ
May 24th 2018, 11:05am
Briefingcom @Briefingcom
$KPTI: Wedbush cuts to Neutral
May 24th 2018, 11:05am
TipRanksFeed @TipRanksFeed
5-star analyst Edward White from H.C. Wainwright rated $KPTI w/a Buy. https://t.co/nmLBuDTNDS
May 24th 2018, 10:05am
kuritzmike @kuritzmike
RT @odibro: $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274…
May 24th 2018, 10:05am
pennpenn2323 @pennpenn2323
$KPTI loading again at this level
May 24th 2018, 9:05am
tom_mcdaniels @tom_mcdaniels
$kpti up over 80% this year. Data soon. Just being cautious I guess. They don’t want to stick there neck out. Take… https://t.co/oJCnDDxl1B
May 24th 2018, 9:05am
WeekHerald @WeekHerald
Karyopharm Therapeutics $KPTI Forecasted to Earn FY2018 Earnings of -$2.67 Per Share https://t.co/yZCTKRjn7a
May 24th 2018, 9:05am
Briefingcom @Briefingcom
$KPTI: Karyopharm Therapeutics and Antengene enter into exclusive license agreement; KPTI to receive $12 mln upfront https://t.co/nLECmYPuBO
May 24th 2018, 9:05am
osok762 @osok762
RT @Karyopharm: $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-…
May 24th 2018, 9:05am
tom_mcdaniels @tom_mcdaniels
$kpti if this gets out of hand I will be adding today.
May 24th 2018, 9:05am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $KPTI (-3.5% pre) Wedbush Downgrades Karyopharm Therapeutics to Neutral. $19 PT https://t.co/3n3cXnc9iO
May 24th 2018, 8:05am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $KPTI (-3.5% pre) Karyopharm inks product commercialization deal in China valued at up to $162M - SA https://t.co/eip1lA…
May 24th 2018, 8:05am
OpenOutcrier @OpenOutcrier
$KPTI (-3.5% pre) Wedbush Downgrades Karyopharm Therapeutics to Neutral. $19 PT https://t.co/3n3cXnc9iO
May 24th 2018, 8:05am
OpenOutcrier @OpenOutcrier
$KPTI (-3.5% pre) Karyopharm inks product commercialization deal in China valued at up to $162M - SA https://t.co/eip1lAAP7a
May 24th 2018, 8:05am
dispatchtribune @dispatchtribune
Karyopharm Therapeutics $KPTI Forecasted to Earn FY2018 Earnings of -$2.67 Per Share https://t.co/JI4Va3LSLt
May 24th 2018, 8:05am
tom_mcdaniels @tom_mcdaniels
$kpti Is the weakness today due to Wedbush down grade to neutral or low upfront payment for China? I’m focused on S… https://t.co/LBnLzXABYx
May 24th 2018, 8:05am
MarketCurrents @MarketCurrents
Karyopharm inks product commercialization deal in China valued at up to $162M https://t.co/GVHiCX5Dyk #premarket $KPTI
May 24th 2018, 8:05am
TranscriptDaily @TranscriptDaily
Karyopharm Therapeutics $KPTI Downgraded to “Neutral” at Wedbush https://t.co/JQrRNmANhH
May 24th 2018, 7:05am
stocknewsdotcom @stocknewsdotcom
$KPTI Wedbush cuts to neutral https://t.co/UeeTE46trX
May 24th 2018, 7:05am
scrooge_fs @scrooge_fs
Stock $KPTI has just announced an exclusive agreement #pennyStocks #stocks #stockMarket #StockTrading #trader #News
May 24th 2018, 7:05am
Karyopharm @Karyopharm
$KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor… https://t.co/aCrOHG1WCS
May 24th 2018, 7:05am
stocknewsdotcom @stocknewsdotcom
$KPTI Karyopharm Therapeutics and Antengene enter into exclusive license agreement; KPTI to receive $12 mln upfront https://t.co/mffjX5M9dO
May 24th 2018, 7:05am
stockelite @stockelite
$KPTI Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor,… https://t.co/i8Hi3mhnMP
May 24th 2018, 7:05am
odibro @odibro
$KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor… https://t.co/TbjrE7a9OZ
May 24th 2018, 7:05am
GNWLive @GNWLive
Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor $KPTI https://t.co/OSQOx8lifo
May 24th 2018, 7:05am
BioStocks @BioStocks
$KPTI downgraded to Neutral from Outperform at Wedbush.
May 24th 2018, 6:05am
dispatchtribune @dispatchtribune
Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/QnMCIqv3q4
May 24th 2018, 2:05am
OlympiaReport @OlympiaReport
Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/qFP8NwilXW
May 24th 2018, 2:05am
TranscriptDaily @TranscriptDaily
Karyopharm Therapeutics $KPTI Stock Price Down 5.3% After Insider Selling https://t.co/l5tKUUobeK
May 24th 2018, 1:05am
tom_mcdaniels @tom_mcdaniels
After today there’s only 6 trading days till #SEAL $kpti https://t.co/aS72Cd3DYN
May 23rd 2018, 3:05pm
registrarjourn @registrarjourn
Investment Analysts’ Recent Ratings Updates for Karyopharm Therapeutics $KPTI https://t.co/30mL8m7iCx
May 23rd 2018, 10:05am
dispatchtribune @dispatchtribune
Investment Analysts’ Recent Ratings Updates for Karyopharm Therapeutics $KPTI https://t.co/0IFnJ2t9ov
May 23rd 2018, 10:05am
ConsumerFeed @ConsumerFeed
Karyopharm Therapeutics Expected to Post FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/FujrUwLvRF
May 23rd 2018, 7:05am
RatingsNetwork @RatingsNetwork
Cantor Fitzgerald Sets Karyopharm Therapeutics FY2019 Earnings Estimates at ($2.43) EPS. https://t.co/wAbU5QJ8ma $KPTI #KPTI
May 23rd 2018, 7:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.